Next quarter’s earnings estimate for CYTO is -$2.34 with a range of -$2.34 to -$2.34. The previous quarter’s EPS was ―. CYTO beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.49% of the time in the same period. In the last calendar year CYTO has Underperformed its overall industry.

CYTO Sales Forecast

Next quarter’s sales forecast for CYTO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were ―. CYTO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.20% of the time in the same period. In the last calendar year CYTO has Underperformed its overall industry.

CYTO Analyst Recommendation Trends

Rating

Jul 16

Aug 16

Nov 16

Jun 17

Oct 18

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CYTO has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CYTO average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxxxxxxxxxxxxxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CYTO Stock Forecast FAQ

What is CYTO’s average 12-month price target, according to analysts?

Currently, no data Available

What is CYTO’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CYTO, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CYTO a Buy, Sell or Hold?

Currently, no data Available

What is Altamira Therapeutics’s price target?

Currently, no data Available

What do analysts say about Altamira Therapeutics?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of CYTO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing